Hepatitis Antibodies
Hepatitis is an inflammation of your liver, often caused by an infection. About 95 percent of hepatitis infections are caused by one of five viruses: hepatitis A, B, C, D, or E and the symptoms of all of these infections are similar. Immune system makes IgM antibodies when you are first infected with HAV. It can take 14 to 50 days to develop symptoms of hepatitis A after you become infected. IgM antibodies usually begin to appear in your blood five to 10 days before you start having symptoms and can stay in your blood for about six months after the infection. Autoimmune hepatitis is a chronic inflammatory disease in which the immune system attacks healthy liver cells causing damage to the organ. There are three types of autoimmune hepatitis based upon the presence of antibodies in the blood.
Type 1 have antinuclear and smooth muscle antibodies
Type 2 show liver-kidney-microsomal antibodies
Type 3 (is currently not regarded as a clinically distinct AIH subgroup) display SLA/LP antibodies.
Autoimmune hepatitis is a chronic hepatitis characterized by immunologic and auto immunologic features, generally including the presence of circulating autoantibodies and a high total serum gamma globulin, usually confined to the IgG fraction [1]. Most cases respond to anti-inflammatory or immunosuppressive therapy.
- Hepatitis B Surface Antibodies
- Hepatitis B Core Antibodies
- Advances in Hepatitis C Antibodies Tests
Related Conference of Hepatitis Antibodies
5th International conference on Vaccines, Vaccination and Immunization
19th International Conference on Allergy and Clinical Immunology
5th International Conference on Immunology And Immunotherapy
International Conference on Tumor Immunology and Immunotherapy
International Conference on Mucosal Immunology
International Conference on Cancer Immunology and Immunotherapy
2nd International Conference on Parasitology
International Conference on Autoimmunity
2nd International Congress on Neuroimmunology and Therapeutics
5th International Conference on Immunology
2nd International Conference on Innate Immunity
International Allergy Conference
2nd World Congress on Infectious Diseases
Americas Antibody Congress
World Bispecific Antibody Summit
Antibodies in Drug Discovery
11th Annual Biomarkers Congress
6th World ADC Summit
Bio Process International European Summit
Protein Antibody Engineering and Development Summit
Antibody Biology Engineering
Proteins and Antibodies Congress
8th Annual International Congress of Antibodies
Cell Culture Engineering XV
Antibody Engineering and Therapeutics
Protein and Antibody Engineering Summit
International Conference on Tumor Immunology and Immunotherapy
International Conference on Mucosal Immunology
International Conference on Cancer Immunology and Immunotherapy
2nd International Conference on Parasitology
International Conference on Autoimmunity
2nd International Congress on Neuroimmunology and Therapeutics
5th International Conference on Immunology
2nd International Conference on Innate Immunity
International Allergy Conference
2nd World Congress on Infectious Diseases
Americas Antibody Congress
World Bispecific Antibody Summit
Antibodies in Drug Discovery
11th Annual Biomarkers Congress
6th World ADC Summit
Bio Process International European Summit
Protein Antibody Engineering and Development Summit
Antibody Biology Engineering
Proteins and Antibodies Congress
8th Annual International Congress of Antibodies
Cell Culture Engineering XV
Antibody Engineering and Therapeutics
Protein and Antibody Engineering Summit
Hepatitis Antibodies Conference Speakers
Recommended Sessions
- Anti-Cancer Antibodies
- Antibodies Immunogenecity
- Antibodies in Pregnancy
- Antibodies Structure
- Antibody Drug Conjugate
- Antibody Drug Therapy
- Antibody Engineering
- Antibody Humanization Technologies
- Antibody Tests
- Antigens
- Auto Antibodies
- Autoimmune Antibodies
- Biomarkers Development
- Biosimilar monoclonal antibodies
- Cancer Immune therapy
- Hepatitis Antibodies
- Immunoglobulins Structures
- Immunotherapy and Immune Checkpoints
- Infectious Diseases
- Insulin and Diode Antibodies
- Medical Applications
- Monoclonal Antibody Therapy
- Myeloperoxidase Antibodies
- Polyclonal Antibodies
- Recombinant Antibodies
Related Journals
Are you interested in
- Advances in Molecular Immunology - ALLERGY 2024 (France)
- Allergen Identification and Characterization - ALLERGY 2024 (France)
- Biomarkers for Allergy Diagnosis and Treatment - ALLERGY 2024 (France)
- Case Studies in Allergy Diagnosis and Management - ALLERGY 2024 (France)
- Clinical Trials and Translational Research in Allergy and Immunology - ALLERGY 2024 (France)
- Digital Health and Telemedicine in Allergy Care - ALLERGY 2024 (France)
- Epidemiology and Population Studies in Allergic Diseases - ALLERGY 2024 (France)
- Immune Responses to Vaccination - ALLERGY 2024 (France)
- Immunogenetics and Allergic Susceptibility - ALLERGY 2024 (France)
- Immunological Aspects of Drug Allergies - ALLERGY 2024 (France)
- Immunological Basis of Food Allergy - ALLERGY 2024 (France)
- Immunological Mechanisms in Autoimmune Diseases - ALLERGY 2024 (France)
- Immunomodulation in Allergy Management - ALLERGY 2024 (France)
- Immunopathogenesis of Allergic Diseases - ALLERGY 2024 (France)
- Immunotherapy for Allergic Conditions - ALLERGY 2024 (France)
- Inflammatory Pathways in Asthma and Allergic Rhinitis - ALLERGY 2024 (France)
- Mechanisms of Immunodeficiency Diseases - ALLERGY 2024 (France)
- Novel Therapeutic Approaches for Allergic Disorders - ALLERGY 2024 (France)
- Role of Microbiota in Allergic Disorders - ALLERGY 2024 (France)